Patient Derived Vascularized MicroTumor Model of Gastrointestinal Peritoneal Carcinomatosis
Part of paid clinical trials in Orange, California.
- Sponsor
- University of California, Irvine
- Study ID
- NCT05844865
- Status
- Recruiting
Conditions
- Gastrointestinal Peritoneal Carcinomatosis
- Peritoneal Carcinomatosis
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Biospecimen Collection (Blood, Ascites/Peritoneal Wash Fluid and/or Tumor Samples) — OTHERSubjects with a known diagnosis of GI primary tumor with or without PC, with a planned standard of care surgery.
Study Details
This is a pilot study gathering and using samples and data from patients with gastrointestinal peritoneal carcinomatosis. Participants will be asked for permission to provide blood and ascites/peritoneal wash fluid, tumor samples during their planned surgical procedure.
Key Dates
- Start date
- May 4, 2023
- Status verified
- Jul 2025
- Primary completion
- Dec 31, 2026
- Completion
- Dec 31, 2026
Study Design
- Enrollment
- 20 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- BASIC_SCIENCE
Arms
- Other: Subjects with Gastrointestinal Primary Tumor with or without Peritoneal CarcinomatosisSubjects with gastrointestinal (GI) primary tumor with or without peritoneal carcinomatosis who are undergoing planned standard of care (SOC) surgical procedures. Biospecimens such as blood, peritoneal wash fluid and tumor samples will be obtained.
Primary Outcome Measure
Establishment of angioarchitechture of peritoneal lesions through Optical Coherence Tomography Angiography (OCTA) [ Time Frame: Up to 4 years ]
Central Contacts
- Chao Family Comprehensive Cancer Center University of California, Irvine1-877-827-7883
- University of California Irvine Medical
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Chao Family Comprehensive Cancer Center, University of California, Irvine | Orange | California | 92868 |
Find similar trials in Orange, CA
Related Studies
- PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric CancerPHASE1 · Recruiting · City of Hope Medical Center · Duarte, California
- PhI Pilot Study Pafolacianine Inject for Intraoperative Imaging on Outcomes of GI Cancer Peritoneal CarcinomatosisEARLY_PHASE1 · Recruiting · University of California, Irvine · Orange, California
- Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal CavityPHASE2/PHASE3 · Recruiting · ECOG-ACRIN Cancer Research Group · Irvine, California
- Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric CancerPHASE2 · Recruiting · University of Chicago · Chicago, Illinois